Dr. Christopher T. Hagenstad, MD

Dr. Hagenstad practices at Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital.

Dr. Hagenstad's NPI, 1659460244, was assigned on October 12, 2006. Dr. Hagenstad holds Georgia license 052738.

Dr. Hagenstad's primary practice is Northside Hospital Atlanta, at 1000 Johnson Ferry Road, NE, Atlanta, GA 30342 in Fulton County. The practice phone is (404) 851-8000.

Dr. Hagenstad's primary practice is Northside Hospital Atlanta in Atlanta, Georgia, part of Northside Hospital. Dr. Hagenstad is also affiliated with Northside Hospital Forsyth. The medical group on file is North Atlanta Professional Services LLC. Dmand AI also links Dr. Hagenstad to 2 more hospitals, 2 group practices and clinics, 2 medical groups and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hagenstad practices, 7 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Hagenstad's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Hagenstad is licensed in Georgia.

CMS data shows 328 Medicare services from Dr. Hagenstad across 6 procedure codes in 2024, for 145 Medicare patients. Medicare paid $20,209 for them.

CMS counts 145 Medicare patients who saw Dr. Hagenstad in 2024. The largest group is 65 to 74, with 72 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 14% are also on Medicaid. Their average risk score is 2.06, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hagenstad's median patient age at 69, with 67% women.

In 2024, Dr. Hagenstad wrote 1,414 Medicare Part D claims for 220 patients. 80% of them were for generic drugs. CMS names the drug for 1,000 of them, across 38 drugs with 11 or more claims each, at $2,734,635 in total drug cost. In 2023, CMS named 1,013 claims across 42 drugs.

Dr. Hagenstad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 1 paper to Dr. Hagenstad in 2011. Dr. Hagenstad's most frequent co-authors are John Joseph Nemunaitis, MD and Donald Anthony Richards, MD.

Dmand AI links Dr. Hagenstad to 1 clinical trial. Conditions studied include Lymphoma, Mantle-Cell and Lymphoma, Follicular.

CMS Open Payments shows 414 general payments to Dr. Hagenstad from 63 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 96% of the total. Pfizer Inc. paid the most, $785.